Procaps (NASDAQ:PROC) sees fiscal 2022 revenue below consensus, approves new $5 million share buyback by Technical Terrence Team 02/13/2023 0 The Latin American health and pharmaceutical firm Procaps (NASDAQ: PROC) on Monday reported preliminary revenue estimates for fiscal 2022 that ...